REQUEST FOR PROPOSAL No. 03/2023-ABM – Phase II, Proof-of-Concept, clinical trial
The order is carried out in connection with the preparation of an application for co-financing as part of the competition: Development of targeted or personalised medicine based on nucleic acid and small molecule compounds-based medicinal products _ABM/2022/6, financed by the Medical Research Agency and in line with Call for proposals Regulation of the competition.
We hereby look for a Contractor ready to perform the Project: Preparation and comprehensive execution of the phase II, Proof-of-Concept, clinical trial in order to assess efficacy, pharmacokinetics, pharmacodynamics and safety of chitinase inhibitor OATD-01 in patients with active pulmonary sarcoidosis.
Please find attached the following documents:
On February 7, 2023, the Ordering Party updated the Appendix 7. The changes are marked in red and appropriately crossed out.
The Ordering Party provides answers to questions send by 09/02/2023 12:00 PM (CET).
03_2023_Questions to the Request for Proposal